A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

NCT06831370 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: Brentuximab Vedotin
DRUG: Doxorubicin
DRUG: Vinblastine
DRUG: Dacarbazine

Sponsor

Takeda